Law360, New York (August 03, 2006, 12:00 AM ET) -- A New Jersey district court has rejected Apotex Inc.’s generic challenge to Daiichi Sankyo Co.’s Floxin Otic, handing the Japanese pharmaceutical giant a crucial victory in the long-simmering patent brawl over the groundbreaking ear-drop medicine.
Judge William G. Bassler of the U.S. District Court for the District of New Jersey granted Daiichi’s request for summary judgment, ruling that its method-of-treatment patent is valid and enforceable and was infringed by the Canadian manufacturer's generic product.
Daiichi confirmed the news on Thursday, revealing in a filing with the...
Apotex Loses Battle With Daiichi Over Ear-Drop Patent
To view the full article, take a free trial now.
